|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| A61K 31/517 | |||
| A61K 39/395 | |||
| A61K 31/505 |
| (11) | Number of the document | 2066353 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07804404.7 |
| Date of filing the European patent application | 2007-09-27 | |
| (97) | Date of publication of the European application | 2009-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2013-01-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2007/003667 |
| Date | 2007-09-27 |
| (87) | Number | WO 2008/037996 |
| Date | 2008-04-03 |
| (30) | Number | Date | Country code |
| 827483 P | 2006-09-29 | US |
| (72) |
RYAN, Anderson, Joseph, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY |
| COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY |